Enliven Therapeutics Inc

NAS:ELVNHealthcareCBOEFTSE:MRUTNASDAQ:NBI

$38.70+3.70%At closeAt close · Tue 20 Oct · ≈ AED 142.13 · Market cap $2.84B · Next earnings Wed 11 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Return on equity	−22.5%	−23.2%	49.0%	−29.1%	−28.7%	−22.6%	−22.6%	+0.0 pts
Return on assets	−20.9%	−21.8%	−45.2%	−26.3%	−27.3%	−21.8%	−21.8%	+0.0 pts
Return on capital employed	−11.0%	−23.0%	−52.7%	−34.0%	−33.7%	−26.0%	—	—
Debt / equity	0.0×	0.0×	−0.0×	0.0×	0.0×	0.0×	0.0×	+0.0%
Debt / assets	0.0%	0.1%	0.4%	0.1%	0.0%	0.1%	—	—
Interest coverage	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Current ratio	14.5×	19.2×	8.0×	10.3×	20.0×	28.7×	28.7×	+0.0%
Quick ratio	14.5×	19.2×	8.0×	10.3×	20.0×	28.7×	—	—
Cash ratio	7.6×	19.1×	7.8×	3.9×	7.8×	6.0×	6.0×	+0.0%
Asset turnover	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.